semaglutide type 1 diabetes trial Ozempic lowers total daily insulin dose in SELECT Trial

The UTSW research revealed that exclusive GLP-1RA use among those treated for obesity in this age group rose from 88.2% between May and November in 2022 to 96.1% between June 2025 and January 2026

All data comes from published trials and Eli Lilly press releases

They want to ensure that while the drug helps with psoriasis, it doesnt cause other immune-related issues

Our providers guide this transition with appropriate monitoring and adjust dosing based on your response

Always dissolve the powder by gently rolling or swirling the vial

Ridha-Salman H et al (2024b) The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation